Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haizeng Zhang

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 15, 2015
[Surgical management of patients with pathologic complete response in the primary tumor after neoadjuvant chemotherapy for rectal cancer]Jian Cui, Lin Yang, Lei Guo, et al.
Cancers|December 30, 2025
A Comprehensive Evaluation of Lymph Node Staging and a Proposal to Subdivide N2b Category in Colorectal Cancer PatientsKexing Xi, Yunlong Wu, Lin Feng, et al.
International Journal of Clinical and Experimental Pathology|December 15, 2010
Cell cycle biology of fibrolamellar hepatocellular carcinomaSadhna Dhingra, Wei Li, Dongfeng Tan, et al.
Oncotarget|March 14, 2019
Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapyJian Cui, Lin Yang, Lei Guo, et al.
Annals of Translational Medicine|May 14, 2021
Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapyTianlei Xu, Lin Zhang, Liang Yu, et al.
Oncotarget|January 20, 2017
The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapyJian Cui, Lin Yang, Lei Guo, et al.
Frontiers in Cell and Developmental Biology|February 21, 2022
Ferroptosis due to Cystathionine γ Lyase/Hydrogen Sulfide Downregulation Under High Hydrostatic Pressure Exacerbates VSMC DysfunctionRuxi Jin, Ruixue Yang, Changting Cui, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 18, 2024
DNA methylation biomarkers for predicting lymph node metastasis in colorectal cancerYu Sun, Deyang Kong, Qi Zhang, et al.
BMC Cancer|July 21, 2022
Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort studyXiu Liu, Kai Ou, Xiaoting Ma, et al.
Journal of Gastrointestinal Oncology|January 12, 2026
The optimal number of lymph nodes examined for rectal cancer patients undergoing neoadjuvant long-course chemoradiotherapyKexing Xi, Lin Feng, Tianlei Xu, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 15, 2015
[Surgical management of patients with pathologic complete response in the primary tumor after neoadjuvant chemotherapy for rectal cancer]Jian Cui, Lin Yang, Lei Guo, et al.
Cancers|December 30, 2025
A Comprehensive Evaluation of Lymph Node Staging and a Proposal to Subdivide N2b Category in Colorectal Cancer PatientsKexing Xi, Yunlong Wu, Lin Feng, et al.
International Journal of Clinical and Experimental Pathology|December 15, 2010
Cell cycle biology of fibrolamellar hepatocellular carcinomaSadhna Dhingra, Wei Li, Dongfeng Tan, et al.
Oncotarget|March 14, 2019
Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapyJian Cui, Lin Yang, Lei Guo, et al.
Annals of Translational Medicine|May 14, 2021
Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapyTianlei Xu, Lin Zhang, Liang Yu, et al.
Oncotarget|January 20, 2017
The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapyJian Cui, Lin Yang, Lei Guo, et al.
Frontiers in Cell and Developmental Biology|February 21, 2022
Ferroptosis due to Cystathionine γ Lyase/Hydrogen Sulfide Downregulation Under High Hydrostatic Pressure Exacerbates VSMC DysfunctionRuxi Jin, Ruixue Yang, Changting Cui, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 18, 2024
DNA methylation biomarkers for predicting lymph node metastasis in colorectal cancerYu Sun, Deyang Kong, Qi Zhang, et al.
BMC Cancer|July 21, 2022
Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort studyXiu Liu, Kai Ou, Xiaoting Ma, et al.
Journal of Gastrointestinal Oncology|January 12, 2026
The optimal number of lymph nodes examined for rectal cancer patients undergoing neoadjuvant long-course chemoradiotherapyKexing Xi, Lin Feng, Tianlei Xu, et al.
Pageof 5